Head-to-head trials show tirzepatide producing 3-5 percentage points greater weight loss at comparable timepoints
Utility: Acetyl L-Carnitine+ helps mobilize fat mass and reduce fatigue perception, supporting physical performance and weight control
"It's not a randomized control trial, and in particular it's not a controlled trial
Conflict of interest DK has received research support from Sanofi, Tanabe Pharma, Terumo, Behringer Ingelheim, Kyowa Kirin, Sumitomo Dainippon Pharma, Ono Pharmaceutical and Takeda Pharmaceutical as well as speaker honoraria from Novo Nordisk Pharma, Sanofi, and Takeda Pharmaceutical
respectively) [9]
It also aided peripheral nerve regeneration after transection